Cormedix Inc (CRMD) Stock Price, Quote & News

Company Profile

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was in...

Industry: Biotechnology

Sector: Healthcare

Phone: 908 517 9500

Fax: 908 375 8272

Website: www.cormedix.com

Address:

300 Connell Drive, Suite 4200, Berkeley Heights, United States

Justrise07 Jan. 14 at 5:17 PM

$ROLR next profit moved to $CRMD for ride to 15

0 · Reply

Justrise07 Jan. 14 at 5:00 PM

$VKTX like all others moving to $NVAX & $CRMD for ride to 15 buyout

0 · Reply

CaptainMayhem Jan. 14 at 4:42 PM

$CRMD expecting a nice little rebound to atleast $9.

0 · Reply

Brunoez Jan. 14 at 4:37 PM

$CRMD Quick poll: Since TLPH appears to be Joe's next acquisitions, how many CRMD investors here are also buying TLPH?? Looks like an easy gain on the surface, but all bets are off when you consider the "Joe Factor".

3 · Reply

Miketj Jan. 14 at 4:16 PM

$CRMD was able to get some more today @7.07 was in church with the child like all Wednesdays but managed to get the FOMO play avg down to 7.45😎. Was over 9 prior to this wonderful dip✌️ GLA

0 · Reply

S2730 Jan. 14 at 3:53 PM

$CRMD KCAPA>TDAPA

0 · Reply

S2730 Jan. 14 at 3:35 PM

$CRMD Congressional Committee Schedule for those who wish to keep an eye on legislation. https://www.congress.gov/committee-schedule/daily/2026/01/14?q=%7B%22senate-committee%22%3A%22Finance%22%7D

1 · Reply

nanoled2020 Jan. 14 at 2:56 PM

$CRMD possible catalyst. Kidney Care Access Protection Act (likely the "KDAPA" referenced) is bipartisan legislation introduced in 2025 (S.2730/H.R.6214).18bde3868df2 Key details: Extends TDAPA to ≥3 years for new renal dialysis drugs/biologics (post-2020 approvals).240975 Adds permanent post-TDAPA payment adjustment to ESRD bundled rate.fc8409 Extends TPNIES for innovative devices; clarifies comorbid drug exclusions; supports Medicare Advantage payments.e6cdc5 Purpose: Improve Medicare access to innovative ESRD therapies, sustain provider reimbursement.7b0467 Pending as of Jan 2026. - ai

1 · Reply

nanoled2020 Jan. 14 at 2:52 PM

$CRMD Possible catalyst: CEO comments at JPM conference on pending KDAPA legislation. - AI realtime analysis

1 · Reply

altair787 Jan. 14 at 2:46 PM

$CRMD I have certainly seen my total profit on CRMD slide back significantly. Sad to have lost so much momentum here. Joe has done a great job losing that momentum. CEO's rarely care about retail investors. Just a way of life for those of us that are not part of the in crowd in the markets.

2 · Reply

CorMedix Inc. (CRMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 9, 2026, 8:30 AM EST - 5 days ago

CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Jan 8, 2026, 1:37 PM EST - 5 days ago

Why is CorMedix stock crashing today: is it worth buying on the dip?

Jan 8, 2026, 8:05 AM EST - 6 days ago

CorMedix Therapeutics Announces Leadership and Board Updates

Jan 8, 2026, 8:00 AM EST - 6 days ago

CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates

Dec 18, 2025, 8:00 AM EST - 27 days ago

CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath

Nov 14, 2025, 2:56 PM EST - 2 months ago

CorMedix: Raised Guidance, NOL Confidence, And Rezzayo Optionality Justify A Hold Rating

Nov 12, 2025, 4:05 PM EST - 2 months ago

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

TLPH

Nov 12, 2025, 11:49 AM EST - 2 months ago

CorMedix Q3 Profit Soars As DefenCath Dialysis Demand Exceeds Expectations

Nov 12, 2025, 11:11 AM EST - 2 months ago

CorMedix Inc. (CRMD) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 7:30 AM EST - 2 months ago

CorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 Guidance

Oct 31, 2025, 8:30 AM EDT - 2 months ago

CorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025

Oct 23, 2025, 11:29 PM EDT - 2 months ago

CorMedix: Strong Buy After Strong Developments And A Strategy Before Earnings

Oct 23, 2025, 8:30 AM EDT - 2 months ago

CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath

Oct 22, 2025, 4:05 PM EDT - 2 months ago

Halper Sadeh LLC Encourages CorMedix Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 20, 2025, 9:42 AM EDT - 3 months ago

CRMD, RANI, CELC, RAPT: four biotech stocks flying high today and why

CELC RANI RAPT

Oct 20, 2025, 7:30 AM EDT - 3 months ago

CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance

Sep 29, 2025, 8:30 AM EDT - 3 months ago

CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO

Sep 22, 2025, 4:46 AM EDT - 4 months ago

CorMedix: Strong Adoption Curve And Policy Environment

Sep 10, 2025, 1:18 PM EDT - 4 months ago

CorMedix Inc. (CRMD) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 8:30 AM EDT - 4 months ago

CorMedix Announces Strategic Minority Investment in Talphera

TLPH

Sep 8, 2025, 8:30 AM EDT - 4 months ago

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

TLPH

Sep 2, 2025, 7:30 AM EDT - 4 months ago

CorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team

Aug 28, 2025, 8:30 AM EDT - 4 months ago

CorMedix to Participate in Upcoming Investor Conferences

Aug 26, 2025, 2:41 AM EDT - 5 months ago

CorMedix: The Undervalued Breakthrough

Aug 8, 2025, 3:16 PM EDT - 5 months ago

CorMedix, Inc. (CRMD) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 10:49 AM EDT - 5 months ago

CorMedix to Buy Melinta Therapeutics for $300 Million

Aug 7, 2025, 7:10 AM EDT - 5 months ago

Melinta Therapeutics Announces Strategic Acquisition by CorMedix, Underscoring Its Portfolio Value and Industry Leadership

Aug 7, 2025, 7:00 AM EDT - 5 months ago

CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings

Aug 7, 2025, 7:00 AM EDT - 5 months ago

Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

Jun 30, 2025, 2:24 PM EDT - 7 months ago

CorMedix Analyst Says Investors Could Be Further Rewarded

Jun 30, 2025, 2:14 PM EDT - 7 months ago

CorMedix Seems Significantly Undervalued

Jun 27, 2025, 9:09 AM EDT - 7 months ago

Concentrix Posts Downbeat Earnings, Joins CorMedix And Other Big Stocks Moving Lower In Friday's Pre-Market Session

CNXC

Jun 27, 2025, 8:00 AM EDT - 7 months ago

CorMedix Inc. Announces Pricing of Public Offering of Common Stock

Jun 26, 2025, 4:01 PM EDT - 7 months ago

CorMedix Inc. Announces Proposed Public Offering of Common Stock

Jun 23, 2025, 7:30 AM EDT - 7 months ago

CorMedix inc. Announces Customer Implementation

Jun 5, 2025, 12:37 AM EDT - 7 months ago

CorMedix: DefenCath In Exponential Growth Phase With Robust Market Position

Jun 4, 2025, 12:41 PM EDT - 8 months ago

CorMedix: Exceeding Expectations

May 30, 2025, 8:30 AM EDT - 8 months ago

CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference

May 15, 2025, 8:30 AM EDT - 8 months ago

CorMedix Inc. to Participate in the RBC Global Healthcare Conference

May 6, 2025, 11:59 AM EDT - 9 months ago

CorMedix, Inc. (CRMD) Q1 2025 Earnings Call Transcript

May 6, 2025, 7:30 AM EDT - 9 months ago

CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

Apr 29, 2025, 8:30 AM EDT - 9 months ago

CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025

Apr 8, 2025, 7:30 AM EDT - 10 months ago

Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance

Apr 2, 2025, 8:30 AM EDT - 10 months ago

CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

Mar 28, 2025, 3:01 AM EDT - 10 months ago

CorMedix: A Fair-Priced Biotech Company With A Bright Future

Justrise07 Jan. 14 at 5:17 PM

$ROLR next profit moved to $CRMD for ride to 15

0 · Reply

Justrise07 Jan. 14 at 5:00 PM

$VKTX like all others moving to $NVAX & $CRMD for ride to 15 buyout

0 · Reply

CaptainMayhem Jan. 14 at 4:42 PM

$CRMD expecting a nice little rebound to atleast $9.

0 · Reply

Brunoez Jan. 14 at 4:37 PM

3 · Reply

Miketj Jan. 14 at 4:16 PM

$CRMD was able to get some more today @7.07 was in church with the child like all Wednesdays but managed to get the FOMO play avg down to 7.45😎. Was over 9 prior to this wonderful dip✌️ GLA

0 · Reply

S2730 Jan. 14 at 3:53 PM

$CRMD KCAPA>TDAPA

0 · Reply

S2730 Jan. 14 at 3:35 PM

$CRMD Congressional Committee Schedule for those who wish to keep an eye on legislation. https://www.congress.gov/committee-schedule/daily/2026/01/14?q=%7B%22senate-committee%22%3A%22Finance%22%7D

1 · Reply

nanoled2020 Jan. 14 at 2:56 PM

1 · Reply

nanoled2020 Jan. 14 at 2:52 PM

$CRMD Possible catalyst: CEO comments at JPM conference on pending KDAPA legislation. - AI realtime analysis

1 · Reply

altair787 Jan. 14 at 2:46 PM

2 · Reply

nanoled2020 Jan. 14 at 2:34 PM

$CRMD jumping... Any news?

1 · Reply

btdb Jan. 14 at 2:23 PM

$CRMD It’s my belief that the stock cannot go below 6.50-7, not sure which, and it’s decisional by the convertible holders. While shorting to 7 is insanely profitable for them, damaging the company is not, as their highest profit comes from a mega rise in the company stock due to conversion. If the share price goes below 5-6, it could plummet due to some institutional investors avoiding “penny stocks “ trading below 5/ share. As well, sustained trading at even 7-9 makes further acquisitions difficult and further dilution dangerous for Joe and negatively impacting the company. These are my theses. Nothing more. GLTA

2 · Reply

issapunk Jan. 14 at 2:13 PM

$CRMD If Joe and the board think the SP is so undervalued, how about you use some of your profits from options you sold and bonuses you got to make a real purchase, not a $10K purchase, but a meaningful amount. That would help. A few $100K+ buys from the team and people will take notice.

2 · Reply

Quincsanity Jan. 14 at 2:08 PM

$CRMD Are we rich yet?

1 · Reply

wolfofwestloop Jan. 14 at 12:02 PM

$CRMD if we have a correction or a few ugly days in the market we could be in the 4's or 5's... Keep some dry powder available just in case.

1 · Reply

MoneyGroupLLC Jan. 14 at 10:41 AM

Enter: $CRMD Calls Strike Price: $8 Expiry Date: FEB 20 2026 Buy in Price: $0.28 - $0.40 Sell Price: $0.56 Profit : +100% (Turn every $1 into $2.00) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/

0 · Reply

Viking0919 Jan. 14 at 6:20 AM

$CRMD

0 · Reply

VictoryFormation Jan. 14 at 4:55 AM

$CRMD Was driving down the road in my area a few days ago. This is a road that I don't normally go on so I'm not real familiar with the road or the businesses that are located on it. All of the sudden, I looked to my right and lo and behold, there was a DaVita dialysis center. I felt like stopping in and giving them a piece of my mind. I wanted to go into the treatment area and say to all the patients with catheters, "You're all being put at risk for bloodstream infections because DaVita doesn't use the most effective clinically proven anti-infective catheter lock solution that's currently available today - DefenCath! However, Fresenius and US Renal both use DefenCath. That's where you need to go if you want to have the lowest possible chance of developing a bloodstream infection." Well, that's what I felt like doing.

2 · Reply

Noname2022 Jan. 14 at 2:50 AM

$DVA $CRMD Are you going to do the right thing and start using Defencath?

2 · Reply

Noname2022 Jan. 14 at 1:57 AM

$CRMD $FMS https://jpmorgan.metameetings.net/events/healthcare26/sessions/317381-fresenius-medical-care-ag/webcast?gpu_only=true&kiosk=true

1 · Reply

DragonAlgo Jan. 14 at 1:41 AM

🐉 $CRMD PUT — DragonAlgo® Signal Contract: CRMD PUT Expiry: 2026-02-20 | Strike: $9.00 | Type: PUT Option Plan (premium): Entry: $1.98 Stop: $1.42 TP1: $2.57 TP2: $3.36 TP3: $4.74 🔗 https://dragonalgo.com

1 · Reply

wolfofwestloop Jan. 14 at 1:40 AM

$CRMD They have now become a huge BO target... Unfortunately 15-20 will be the price...

8 · Reply

Market Cap	563.34M
Revenue (ttm)	43.47M
Net Income (ttm)	-17.93M
EPS (ttm)	N/A
PE Ratio	5.57
Forward PE	2.65
Profit Margin	-41.25%
Debt to Equity Ratio	0.00

Volume	2,763,500
Avg Vol	3,458,828
Day's Range	N/A - N/A
Shares Out	78.79M
Stochastic %K	1%
Beta	1.36
Analysts	Strong Sell
Price Target	$17.43